---
title: "Primary Blood Grouping MSC"
ocid: "ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577.json"
source: "Contracts Finder"
current_stage: "Tender"
buyer: "NHS BLOOD AND TRANSPLANT"
published: "2022-04-13"
---

# Primary Blood Grouping MSC

Buyer: NHS BLOOD AND TRANSPLANT  
Current stage: Tender  
OCID: ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577.json)

## Summary

The NHS Blood and Transplant is seeking suppliers for the "Primary Blood Grouping MSC" service, which is integral to the health care industry. This selective tender, with competitive negotiation, aims to establish an end-to-end integrated service encompassing equipment, goods, installation, maintenance, and ongoing support for blood donation screening. The tender period concludes on 28 April 2022, while the contract is set to commence on 1 April 2023 and last until 31 March 2033. Delivery will primarily occur at two NHSBT sites located in Manchester and Filton, with a total contract value estimated at £50 million.

This procurement presents significant opportunities for businesses, particularly those involved in healthcare technology, diagnostic equipment, and related services. Companies that manufacture or supply CE/UKCA marked in vitro diagnostic devices, automation systems, and blood analysis services would be particularly well-suited to compete. Successful candidates will not only need to accommodate current technological standards but also anticipate and integrate future digital innovations for an effective partnership with NHSBT.

## Notice

NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated Service, which must include all the necessary Equipment, Goods, Installation, maintenance, Consumables, Reagents, Software, including an inter-operability provision with NHSBT's existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, Instruments, Consumables and Reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end Service must be capable of producing test results in a format that can be utilised by NHSBT's host IT system (PULSE) (or any replacement system) without the need for changes to PULSE (or any replacement system). The Equipment should also be compatible with NHSBT's manufactured reagents and where possible, with those from third party reagent suppliers. NHSBT requires a high throughput blood and non-blood donation screening for primary blood grouping testing system(s), for ABO and Rh D typing (as a minimum DIV, DV and DVI), antibody screening and red cell phenotyping including Rh for donor blood samples. As a minimum, the Service provided must be capable of undertaking the testing of blood and non-blood donor samples and providing accurate results for the following:* ABO group* Rh phenotype D, C, c, E, e * Kell * Atypical antibody screen* High titre anti-A and anti-B screening* Red cell phenotypes S, s, Jka, Jkb (test system should include an option of Cw and M). All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors. The annual estimated throughput of the NHSBT primary automated blood sample testing equipment tests approximately 1,500,000 to 1,700,000 donations (of which ca. 1500 - 2100 are non-blood donors) are tested per annum across two NHSBT testing sites, namely Manchester and Filton. The Tenderer must also be able to accommodate technological and digital changes in the current and future such that NHSBT is able to access the state-of-the art digital developments and IT solutions in the diagnostics market.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/b5f5871a-5d73-4529-b06e-40295db39c49 |
| Notice type | Tender Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Selective |
| Procurement method details | Competitive procedure with negotiation (above threshold) |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 13 Apr 2022 |
| Submission deadline | 28 Apr 2022 |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 31 Mar 2023 - 31 Mar 2033 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £50,000,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Active |
| Lots status | Not specified |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS BLOOD AND TRANSPLANT |
| Locality | FILTON, BRISTOL |
| Post town | Bristol |
| Postcode | BS34 7QH |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK5 West of England |
| ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire |
| Local authority | South Gloucestershire |
| Electoral ward | Filton |
| Westminster constituency | Filton and Bradley Stoke |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products
- 38 - Laboratory, optical and precision equipments (excl. glasses)
- 48 - Software package and information systems
- 71 - Architectural, construction, engineering and inspection services
- 73 - Research and development services and related consultancy services
- 85 - Health and social work services

### Codes

- 33696200 - Blood-testing reagents
- 38434520 - Blood analysers
- 48921000 - Automation system
- 71632000 - Technical testing services
- 73430000 - Test and evaluation
- 85111810 - Blood analysis services

## Release History

- 13 Apr 2022 at 20:26 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/b5f5871a-5d73-4529-b06e-40295db39c49

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/b5f5871a-5d73-4529-b06e-40295db39c49
  13th April 2022 - Opportunity notice on Contracts Finder

## Notice URLs

- https://www.transfusionguidelines.org/red-book

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-43d69e82-cdbe-4a9c-8ddf-5d6300299577.json.
